menu search

Gamida cell to present corporate highlights at multiple upcoming investor conferences

BOSTON--( BUSINESS WIRE )--Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapies for patients with hematologic ...

November 23, 2022, 8:00 am

Urogen pharma: jelmyto sales growing steadily, concerns remain

Shares have lost nearly two-thirds of their value over the past 3 years. RTGel platform is a great fit for bladder ...

November 21, 2022, 1:30 pm

Cardiff oncology to present at upcoming investor conferences

SAN DIEGO , Nov. 21, 2022 /PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to ...

November 21, 2022, 10:52 am

Gsk second-line applications of new cancer drug will be restricted

GSK PLC (LSE:GSK, NYSE:GSK) said the second-line applications of its cancer drug will be limited in scope. The front-line use of Zejula, which has bee...

November 11, 2022, 2:28 am

Celcuity inc. schedules release of third quarter 2022 financial results and webcast/conference call

MINNEAPOLIS, MN/ ACCESSWIRE / November 3, 2022 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targete...

November 3, 2022, 8:50 am

Erasca to present at the morgan stanley global healthcare conference

SAN DIEGO, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discoveri...

September 9, 2022, 8:31 am

Aim immunotech to present at the h.c. wainwright 24th annual global investment conference

OCALA, Fla., Sept. 07, 2022 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM” or the “Company”), an immuno-pharma company fo...

September 7, 2022, 7:25 am

Nuvalent to present preliminary phase 1 data from arros-1 clinical trial of nvl-520 at 34th eortc-nci-aacr symposium and announces pipeline updates

Preliminary Dose Escalation Data on ROS1-selective Inhibitor NVL-520 to be Presented in the "New Drugs on the Horizon" Oral Plenary Session New Precli...

September 7, 2022, 6:30 am

Poseida therapeutics: collaboration agreement with roche helps validate genetic engineering tech

Poseida announced a collaboration agreement on Aug.3 focused on allogeneic CAR-T Program in hematologic cancer...

September 4, 2022, 3:30 am

Imv inc. to present at two investor conferences in september

DARTMOUTH, Nova Scotia, & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $IMV #DeliveryPlatform--IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage company dev...

September 1, 2022, 7:05 am

Imv inc. to announce second quarter 2022 results and host a conference call and webcast on august 11, 2022

DARTMOUTH, Nova Scotia, & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $IMV #DeliveryPlatform--IMV Inc. (Nasdaq: IMV; TSX: IMV) (“IMV” or “the Company�...

August 4, 2022, 7:05 am

Volitionrx limited inks r&d collaboration deals with xenetic biosciences and salarius pharmaceuticals in push to develop cancer treatments

VolitionRx (NYSE-A:VNRX) Limited has inked a pair of research and development collaborations that will develop targeted, adoptive cell therapies to ...

August 2, 2022, 10:07 am

Revolution medicines to report financial results for second quarter 2022 after market close on august 9, 2022

REDWOOD CITY, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel ...

July 28, 2022, 4:02 pm

Why is neximmune (nexi) stock up 30% today?

NexImmune appears to be making headway in the company's ongoing battle against HPV-related cancers -- a...

July 15, 2022, 11:55 am

Amazon launches cancer vaccine clinical trial in partnership with fred hutchinson

Amazon is listed as a collaborator on a filing for an FDA-approved clinical trial, which seeks to develop vaccines to treat breast and skin ...

July 12, 2022, 9:31 am

Exor: another step into healthcare

Founded 125 years ago in Lyon, the group controlled by the Mérieux family is active in research on infectious diseases and ...

July 11, 2022, 5:44 pm

Harpoon therapeutics: a t-cell engager platform and a negative enterprise value makes it a candidate for my 'bio boom' portfolio

Harpoon Therapeutics has an intriguing platform that can generate stable bispecific immunotherapies using their TriTAC technology. Their “off-the-sh...

July 7, 2022, 5:34 pm

Pyxis oncology to present at h.c. wainwright preclinical cancer drug discovery conference

CAMBRIDGE, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), an oncology company focused on developing next-generation the...

June 28, 2022, 6:35 am

Aim immunotech boosts intellectual property with new netherlands utility patent covering ampligen and dsrna products aimed at covid-19

AIM ImmunoTech Inc (NYSE:AIM) revealed that the Netherlands Patent Office (Octrooicentrum Nederland) has issued Patent No 2027383 - a utility patent ...

June 13, 2022, 10:02 am

Revolution medicines to participate in the 43rd annual goldman sachs global healthcare conference

REDWOOD CITY, Calif., June 09, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing target...

June 9, 2022, 4:02 pm


Search within

Pages Search Results: